Search results for "folic acid"

showing 10 items of 92 documents

The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with …

2006

Hyperhomocysteinemia is considered an independent risk factor for atherosclerosis, atherothrombosis and Venous ThromboEmbolism (VTE) [1], [2] and [3]. Normal total plasma homocysteine concentrations range from 5 to 15 μmol/L in the fasting state. Hyperhomocysteinemia is classified as moderate (homocysteine concentration, 15 to 30 μmol/L), intermediate (> 30 to 100 μmol/L), and severe (> 100 μmol/L) on the basis of concentrations measured during fasting. Although severe hyperhomocysteinemia is rare, mild hyperhomocysteinemia occurs in approximately 5% to 7% of the general population. In this case, patients are typically asymptomatic until the third or fourth decade of life when premature Cor…

Malecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyHyperhomocysteinemiaTime FactorsHomocysteinePopulationHyperhomocysteinemiaGastroenterologyAsymptomaticchemistry.chemical_compoundFolic AcidRecurrenceRisk FactorsInternal medicineMedicineHumansIn patientRisk factoreducationHomocysteineAgededucation.field_of_studybusiness.industrynutritional and metabolic diseasesHematologyMiddle Agedmedicine.diseaseB vitaminsEndocrinologyTreatment OutcomechemistryCardiovascular DiseasesVitamin B ComplexPlasma homocysteineFemalemedicine.symptombusinessThrombosis research
researchProduct

The aminothiol redox status in haemodialysis patients does not improve with folate therapy.

2008

Patients on haemodialysis suffer from high cardiovascular morbidity and mortality, and oxidative stress may play a role in the pathophysiology of cardiovascular disease in these patients. Hyperhomocysteinemia is common in dialysis patients and may have pro-oxidant effects. Moreover, the redox status of the major plasma aminothiols (homocysteine [Hcy], cysteine and cysteinylglycine) may be regarded as a biomarker of oxidative stress. In the present study, we investigated the aminothiol redox status during a period of homocysteine-lowering therapy with folinic acid.In the first part of the study, 32 stable patients receiving maintenance haemodialysis were compared with 32 reference subjects. …

Malemedicine.medical_specialtyHyperhomocysteinemiaHomocysteineClinical Biochemistrymedicine.disease_causeGastroenterologychemistry.chemical_compoundFolinic acidFolic AcidRenal DialysisInternal medicinemedicineHumansSulfhydryl CompoundsAgedbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseRedox statusPathophysiologySurgerychemistryBiomarker (medicine)FemalebusinessOxidation-ReductionOxidative stressCysteinemedicine.drugScandinavian journal of clinical and laboratory investigation
researchProduct

Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke.

2009

Blood levels of total homocysteine (tHcy), cysteine (Cys), total and reduced glutathione (tGSH and rGSH), folic acid (FA), and vitamin B(12) (B(12) change during ischemic stroke as accompaniment of the tissue damage. The relationship between these changes remains scantly investigated. We evaluated the variation of these molecules in the 48 h after acute large artery atherothrombotic stroke (LAAS) and searched for the presence of matched variation of them. The study involved 50 subjects affected by acute LAAS and 49 healthy controls. Plasma levels of tHcy and Cys were significantly higher and serum levels of FA and B(12) and plasma levels of rGSH were significantly lower in the patients than…

Malemedicine.medical_specialtyLarge artery atherothrombotic strokeHomocysteineAtherothrombotic strokeHyperhomocysteinemiaDermatologyBrain Ischemiachemistry.chemical_compoundFolic AcidRisk FactorsSettore BIO/10 - BiochimicaInternal medicinemedicineHumansVitamin B12CysteineVitamin B(12)HomocysteineAgedAged 80 and overbusiness.industryLarge arteryGeneral MedicineGlutathionePlasma levelsVitaminsMiddle AgedGlutathioneReduced glutathioneStrokePsychiatry and Mental healthVitamin B 12EndocrinologychemistryFolic acidBiochemistryAcute DiseaseSettore MED/26 - NeurologiaFemaleNeurology (clinical)Intracranial ThrombosisbusinessCysteineNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Autism and Intellectual Disability Associated with Mitochondrial Disease and Hyperlactacidemia

2015

Autism spectrum disorder (ASD) with intellectual disability (ID) is a life-long debilitating condition, which is characterized by cognitive function impairment and other neurological signs. Children with ASD-ID typically attain motor skills with a significant delay. A sub-group of ASD-IDs has been linked to hyperlactacidemia and alterations in mitochondrial respiratory chain activity. The objective of this report is to describe the clinical features of patients with these comorbidities in order to shed light on difficult diagnostic and therapeutic approaches in such patients. We reported the different clinical features of children with ID associated with hyperlactacidemia and deficiencies i…

Malemedicine.medical_specialtyPediatricsMitochondrial DiseasesUbiquinoneMitochondrial diseaseautismArticleCatalysislcsh:ChemistryInorganic Chemistrychemistry.chemical_compoundFolic AcidCarnitinemental disordersIntellectual disabilitymedicineHumansHyperlactatemiaCarnitinePhysical and Theoretical Chemistrypossible mitochondrial diseasePsychiatrylcsh:QH301-705.5Molecular BiologySpectroscopyCoenzyme Q10business.industryOrganic ChemistryInfantCognitionVitaminsGeneral Medicinemedicine.diseaseComputer Science ApplicationsMitochondrial respiratory chainlcsh:Biology (General)lcsh:QD1-999chemistryintellectual disabilityChild Development Disorders PervasiveAutism spectrum disorderChild Preschoolmuscular toneAutismFemalebusinessmedicine.drugInternational Journal of Molecular Sciences
researchProduct

Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug deliver…

2020

PEGylated graphene oxide (GO) has shown potential as NIR converting agent to produce local heat useful in breast cancer therapy, since its suitable photothermal conversion, high stability in physiological fluids, biocompatibility and huge specific surface. GO is an appealing nanomaterial for potential clinical applications combining drug delivery and photothermal therapy in a single nano-device capable of specifically targeting breast cancer cells. However, native GO sheets have large dimensions (0.5-5 mu m) such that tumor accumulation after a systemic administration is usually precluded. Herein, we report a step-by-step synthesis of folic acid-functionalized PEGylated GO, henceforth named…

Materials scienceBiocompatibilityPlasma GasesCell SurvivalInfrared RaysBioengineeringNanotechnologyAntineoplastic Agents02 engineering and technology010402 general chemistrySettore CHIM/04 - Chimica Industriale01 natural sciencesNANOMEDICINECell LinePolyethylene GlycolsBiomaterialsBreast cancerBreast cancerFolic AcidCell MovementmedicineNANOPARTICLESABLATIONHumansDoxorubicinCANCER-CELLSAGENTSGraphene oxideDrug Carrierstechnology industry and agriculturePhotothermal therapyPhototherapy021001 nanoscience & nanotechnologymedicine.disease0104 chemical sciencesNanostructuresDrug LiberationTargeted drug deliverySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoMechanics of MaterialsDoxorubicinCancer cellDrug deliveryDoxorubicin HydrochlorideGraphiteSettore CHIM/07 - Fondamenti Chimici Delle Tecnologie0210 nano-technologySYSTEMmedicine.drugMaterials scienceengineering. C, Materials for biological applications
researchProduct

Photothermal Ablation of Cancer Cells Using Folate-Coated Gold/ Graphene Oxide Composite

2017

Objective: A new tumor targeted polymer-coated gold/graphene hybrid has been developed for achieving simultaneously thermoablation and chemoterapy of folate receptor-positive cancer cells. Methods: The gold/graphene hybrid was prepared by depositing gold nanospheres onto graphene oxide and coating it with an inulin-folate conjugate. Paclitaxel was loaded by sonication. The hybrid was characterized by UV-Vis spectroscopy, DSC analysis and SEM microscopy. The cytotoxicity, thermoablation and anticancer activity were evaluated in vitro on MCF-7 and 16 HBE. Results: In vitro tests showed that the paclitaxel-loaded hybrid improved the effectiveness of the drug especially after photothermal treat…

Materials sciencePaclitaxelSonicationOxidePharmaceutical ScienceNanotechnology02 engineering and technologyengineering.material010402 general chemistry01 natural scienceslaw.inventionchemistry.chemical_compoundFolic AcidCoatinglawMicroscopyHumanscancer gold nanoparticles graphene oxide paclitaxelGraphenePhotothermal effectOxidesPhototherapyPhotothermal therapy021001 nanoscience & nanotechnology0104 chemical scienceschemistryColloidal goldMCF-7 CellsengineeringGraphiteGold0210 nano-technologyCurrent Drug Delivery
researchProduct

The methylenetetrahydrofolate reductase C677T polymorphism and the risk of congenital heart diseases: a literature review

2014

Congenital Heart Diseases (CHDs) are the most commonand serious developmental anomaly and the leading non-infectious cause of mortality in the first year of life. Despite the advances in diagnosis and treatment, understanding of the developmental causes and aetiologies of CHDs has been limited. The hyperhomocysteinemia is one of the proved risk factors related to the occurrence of CHDs. The connection between cardiac defects, folate and hyperhomocysteinemia could be explained by a mutation in the methylenetetrahydrofolate reductase (MTHFR) gene. Indeed, the C677T MTHFR mutation produces a thermolabile variant of MTHFR with reduced enzymatic action resulting in higher plasma levels of homocy…

Methylenetetrahydrofolato reductasebiologyFolic acidC677T MTHFR mutationbusiness.industryHyperhomocysteinemiaBioinformaticsSettore MED/40 - Ginecologia E OstetriciaBirth defectMTHFR polymorphismMethylenetetrahydrofolate reductaseMTHFRbiology.proteinMthfr c677tMedicinebusinessCongenital heart disease
researchProduct

Preventing Persistence of HPV Infection with Natural Molecules

2023

Human papillomavirus (HPV) infection is one the most common sexually transmitted infections worldwide. In most cases, the infection is temporary and asymptomatic; however, when persistent, it may lead to lesions that can evolve into cancer in both women and men. Nowadays, prophylactic vaccination is the primary preventive strategy for HPV infections, but vaccines do not cover all types of HPV strains. Scientific research has uncovered the beneficial role of some natural supplements in preventing persistent HPV infections or treating HPV-related lesions. We review the current insight into the roles of natural molecules in HPV infection with a special focus on epigallocatechin gallate (EGCG),…

Microbiology (medical)PersistenceInfectious DiseasesGeneral Immunology and MicrobiologyFolic acidVitamin B12.HAHPV infectionImmunology and Allergyvitamin B12Molecular BiologyEGCGSettore MED/40 - Ginecologia E Ostetricia
researchProduct

Controversial roles of methylenetetrahydrofolate reductase polymorphisms and folate in breast cancer disease

2014

Abstract Breast cancer (BC) represents a highly heterogeneous tumour at both the clinical and molecular levels. Single-nucleotide polymorphisms (SNPs) of the folate-metabolising enzyme methylenetetrahydrofolate-reductase (MTHFR) may modify the association between folate intake and BC and influence plasma folate concentration. The role of folate in BC is equivocal, association studies between the common MTHFR SNPs C677T and A1298C and BC risk are controversial. In this study, I have reviewed observed associations between folate intake, as well as its blood levels, and BC. The purpose of this review is to analyse the role of folate and the two SNPs associated with reduced enzyme activity in B…

Oncologymedicine.medical_specialtyBreast NeoplasmsSingle-nucleotide polymorphismDiseasePolymorphism Single NucleotideFolic AcidBreast cancerRisk FactorsInternal medicinemedicineHumansMthfr c677tFolate intakeBreast cancer; MTHFR; MTHFR A1298C; MTHFR C677TMethylenetetrahydrofolate Reductase (NADPH2)Genetic associationGeneticsBreast cancer MTHFR MTHFR A1298C MTHFR C677Tbiologybusiness.industrymedicine.diseaseMethylenetetrahydrofolate reductaseMutationbiology.proteinFemalebusinessFood Science
researchProduct

Encapsulation of folic acid in different silica porous supports: A comparative study.

2016

Although folic acid is essential to numerous bodily functions, recent research indicates that a massive exposition to the vitamin could be a double-edged sword. In this study, the capacity of different caped mesoporous silica particles (i.e. Hollow Silica Shells, MCM-41, SBA-15 and UVM-7) to dose FA during its passage through the gastrointestinal tract has been evaluated. Results confirmed that the four capped materials were capable to hinder the delivery of FA at low pH (i.e. stomach) as well as able to deliver great amounts of the vitamin at neutral pH (i.e. intestine). Nevertheless, the encapsulation efficiency and the deliver kinetics differed among supports. While supports with large p…

OptimizationVitaminPorous silica supportsSmart deliveryINGENIERIA DE LA CONSTRUCCIONFolic acidTECNOLOGIA DE ALIMENTOSSilicon dioxideKinetics02 engineering and technology010402 general chemistryElectron Microscopy Service of the UPV01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundQUIMICA ORGANICAFolic AcidNeutral phPorosityNutritionChemistryQUIMICA INORGANICAGeneral MedicineMesoporous silica021001 nanoscience & nanotechnologySilicon Dioxide0104 chemical sciencesLarge poreNutrition AssessmentBiochemistryChemical engineeringFolic acid0210 nano-technologyPorosityFood ScienceFood chemistry
researchProduct